HEGPOL: Randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]
- Steffen P Luntz†1,
- Kristina Unnebrink1,
- Monika Seibert-Grafe1,
- Hartwig Bunzendahl3,
- Thomas W Kraus2,
- Markus W Büchler2,
- Ernst Klar4 and
- Peter Schemmer†2Email author
© Luntz et al; licensee BioMed Central Ltd. 2005
Received: 04 July 2005
Accepted: 17 August 2005
Published: 17 August 2005
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|4 Jul 2005||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|26 Jul 2005||Author responded||Author comments - Peter Schemmer|
|Resubmission - Version 3|
|26 Jul 2005||Submitted||Manuscript version 3|
|14 Aug 2005||Author responded||Author comments - Peter Schemmer|
|Resubmission - Version 4|
|14 Aug 2005||Submitted||Manuscript version 4|
|17 Aug 2005||Editorially accepted|
|17 Aug 2005||Article published||10.1186/1471-2482-5-18|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.